Whalegun
Home

Regeneron Pharmaceuticals REGN spent $400K on lobbying in Q3 2023 · Health Issues, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$400,000
Quarter
Q3 2023
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
23/10/20

Up 8.1% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $400K on lobbying in Q3 2023 · Health Issues, Medicare and 1 more issue | Whalegun